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Quercetin is a dietary bioﬂavonoid which has been shown to inhibit lens opaciﬁcation in a number of
models of cataract. The objectives of this study were to determine gene expression changes in human
lens epithelial cells in response to quercetin and to investigate in detail the mechanisms underlying the
responses. FHL-124 cells were treated with quercetin (10 mM) and changes in gene expression were
measured by microarray. It was found that 65% of the genes with increased expression were regulated by
the hypoxia-inducible factor-1 (HIF-1) pathway. Quercetin (10 and 30 mM) induced a time-dependent
increase in HIF-1a protein levels. Quercetin (30 mM) was also responsible for a rapid and long-lasting
translocation of HIF-1a from the cytoplasm to the nucleus. Activation of HIF-1 signaling by quercetin was
conﬁrmed by qRT–PCR which showed upregulation of the HIF-1 regulated genes EPO, VEGF, PGK1 and
BNIP3. Analysis of medium taken from FHL-124 cells showed a sustained dose-dependent increase in
VEGF secretion following quercetin treatment. The quercetin-induced increase and nuclear translocation
of HIF-1a was reversed by addition of excess iron (100 mM). These results demonstrate that quercetin
activates the HIF-1 signaling pathway in human lens epithelial cells.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Flavonoids are a group of polyphenolic compounds ubiquitously
distributed throughout the plant kingdom. They are major
contributors to total dietary antioxidant intake (Hollman et al.,
1999). The ﬂavonol quercetin is the most widely consumed ﬂavo-
noid in the human diet (Lamson and Brignall, 2000) and is partic-
ularly abundant in onions, kale, apples, tea and red wine (Hertog
et al., 1992). Quercetin is a potent antioxidant, the most potent
antioxidant of the entire ﬂavonoid group (Rice-Evans et al., 1996).
Dietary ﬂavonoids have numerous proposed beneﬁts to human
health, which has been largely attributed to their antioxidant
properties. Signiﬁcantly, there is epidemiological evidence that
a quercetin-rich diet is inversely associated with lower incidences
of cancer and cardiovascular diseases (Formica and Regelson, 1995;
Hertog et al., 1993; Knekt et al., 1996, 2002). In relation to cataract,
it has long been recognised that oxidative stress has a signiﬁcant
role to play in the pathophysiology of the disease (Spector, 1995;
Truscott, 2005) and recent experiments clearly show increased
protein oxidation in human lenses with cataract compared tox: þ44 1603 592 003.
n).
All rights reserved.age-matched controls (Hains and Truscott, 2008). Furthermore,
diets rich in antioxidants have been linked with a reduced risk for
cataract in several epidemiological studies (Jacques and Chylack,
1991; Tavani et al., 1996). Whilst much research relating to
protection against cataract by antioxidants has focussed on the
antioxidant vitamins, it is becoming increasingly apparent that the
role of ﬂavonoids in protecting against cataract requires further
consideration (Sanderson and McLauchlan, 2002).
Quercetin and other ﬂavonoids have been shown to have
protective effects against lens opaciﬁcation in in vivo and in vitro
models of cataract (Beyer-Mears and Farnsworth, 1979; Lija et al.,
2006; Sanderson and McLauchlan, 2002; Sanderson et al., 1999). In
a galactosemic neonatal rat model of cataract, both topical and
dietary administration of quercetin was found to diminish cata-
ractogenesis (Beyer-Mears and Farnsworth, 1979). In another rat
model, the occurrence and maturation of selenite-induced cataract
was lowered by quercetin (Lija et al., 2006). We have previously
demonstrated that quercetin effectively inhibited H2O2-induced
lens opaciﬁcation in a lens organ culture oxidative model of cata-
ract (LOCH) (Sanderson et al., 1999). As a potent antioxidant,
quercetinwould be expected to be effective in this model as a result
of direct antioxidant action. However, we also showed that
protection occurred in lenses that had been pre-treated with
quercetin for 24 h, but were exposed to oxidative stress in the
P. Radreau et al. / Experimental Eye Research 89 (2009) 995–1002996absence of quercetin. This suggests that in addition to direct anti-
oxidant effects, quercetin is also able to induce protective mecha-
nisms within the cells.
It is known that antioxidants can cause changes in gene
expression. Much research in this area has focussed on stimulation
of antioxidant defences via the transcription factor Nrf-2 acting at
the antioxidant response element (ARE) (Li and Kong, 2009) and
quercetin has been shown to stimulate this pathway (Hanneken
et al., 2006). However, a number of other pathways have also been
shown to be upregulated by the ﬂavonoid in a variety of cell types
(Gong et al., 2009; Jeong et al., 2009; Kampkotter et al., 2008;
Triantafyllou et al., 2007). In order to explain the mechanism of
how lens cells could be protected by an exposure to quercetin prior
to, but not during, oxidative stress, then such changes in gene
expression must be considered. In the research presented here, we
undertook global gene expression analysis of human lens epithelial
cells exposed to quercetin. Of the genes that were upregulated, the
majority were found to be controlled by the transcription factor
hypoxia-inducible factor-1 (HIF-1). We demonstrate the stimula-
tion of the HIF pathway in lens epithelial cells by quercetin and
show the activation and synthesis of downstream effectors
including vascular endothelial growth factor (VEGF) and erythro-
poietin (EPO).
2. Methods
All chemicals and reagents were from Sigma (Poole, UK) unless
otherwise stated.
2.1. Cell culture
The human lens epithelial cell line (FHL-124) was a kind gift
from Dr. J. R. Reddan (University of Michigan, USA). FHL-124 is
a non-virally transformed cell line generated from human capsule-
epithelial explants (Reddan et al., 1999) showing a 99.5% homology
(in transcript proﬁle) with the native lens epithelium (Wormstone
et al., 2004). FHL-124 were routinely cultured at 35 C in a humid-
iﬁed atmosphere of 95% air and 5% CO2, in Eagle’s Minimal Essential
Medium (EMEM) (Gibco, Paisley, UK) supplemented with 5% v/v
foetal bovine serum (Gibco) and 0.005% w/v gentamicin. Experi-
ments were conducted on cells grown to 90% conﬂuency. Prior to
experimentation, cells were serum starved for 24 h. The cells were
then exposed to quercetin (10 or 30 mM) in serum-free EMEM.
These concentrations of quercetin have previously been shown to
protect lens transparency when rat lenses were pre-incubated with
quercetin for 24 h prior to exposure to oxidative stress (Sanderson
et al., 1999). DMSO was required to solubilise quercetin and as
a result DMSO (0.1% v/v) was present in all solutions including
controls.
2.2. Microarrays
FHL-124cellsweregrown in60mmculturedishes. Total RNAwas
isolated from untreated (control) and 10 mM quercetin-treated cells
(24 h) using RNeasy Mini column extraction kits (Qiagen, Crawley,
UK). Transcription proﬁles were analyzed using 2-colour oligonu-
cleotide DNA arrays printed on epoxy-coated slides (Eady et al.,
2005). Microarrays were produced using a commercial set of 14 000
oligonucleotides (Operon human oligonucleotide set version 1.0;
Operon Biotechnologies, Cologne, Germany). Further details and
validation of the microarrays has been previously described
(Eadyet al., 2005). All test sampleswere hybridised to the arraywith
an FHL-124 reference sample that was common to all arrays.
Hybridised arrays were scanned using an Agilent G2565BA micro-
array scanner system (Agilent Technologies South Queensferry, UK)and imageswere analyzedwith Agilent G2567AA feature extraction
software (Agilent Technologies). Aberrant featureswere detected by
visual inspection and manually ﬂagged. Data were analyzed using
GeneSpring (Agilent Technologies) and normalized using locally
weighted (LoWess) linear regression (Listgarten et al., 2003).
Statistical analysis was performed using Welch’s one way ANOVA
with Benjamini and Hochberg multiple test corrections with
a signiﬁcance level set at p < 0.05. Analysis was performed using
data from 2 independent experiments each with 4 replicates. The
independent experiments were analyzed separately then the ﬁnal
list was derived from the quercetin-regulated genes that were
common to both experiments.
2.3. Western blot analysis
Whole cell lysates from FHL-124 cells were prepared using Daub
lysis buffer (Daub et al., 1997) supplemented with 1 mM phenyl-
methylsulfonyl ﬂuoride (PMSF) and 10 mg/ml aprotinin for 20 min
on ice and centrifuged at 13 000 rpm for 10 min. The protein
concentration in the supernatant was determined using the bicin-
choninic acid protein assay (Pierce, Rockford, IL). Equal amounts of
proteins were separated on 8% SDS-polyacrylamide gels and
transferred to PVDF membrane using a semi-dry transfer cell (Bio-
Rad, Herts, UK). The membrane was blocked with PBS containing
5% w/v non fat dry milk and 0.1% v/v Tween-20, hybridized with
primary antibody followed by incubation with secondary antibody
(Amersham Biosciences, Bucks, UK) and bands were detected using
an ECLþ chemiluminescent blot analysis system (Amersham
Biosciences). Primary monoclonal antibodies to HIF-1a (BD Trans-
duction Laboratories, UK) and b-actin (New England BioLabs,
Hitchin, UK) were used a 1:600 and 1:1000 respectively. Statistical
analysis was performed by unpaired, two-tailed Student’s t test
using Minitab release 14 (Minitab Inc, State College, PA). The
signiﬁcance level was set at p < 0.05.
2.4. Immunocytochemistry
FHL-124 cells were grown onto sterile glass coverslips and
treated with 30 mM quercetin for 0.5, 4 and 24 h. Cells were ﬁxed
with 4% v/v formaldehyde in PBS for 30 min and permeabilised
with PBS containing 0.5% v/v Triton X-100 for 30 min. All washes
were made in PBS-BSA-Igepal (0.02% w/v and 0.05% v/v respec-
tively). Non-speciﬁc sites were blocked with normal goat serum
(1:50 in 1% w/v BSA in PBS). Anti-HIF-1a (1:100) or IgG1 control
(R&D Systems, Abingdon, UK) (both diluted in 1% w/v BSA in PBS at
same concentration of 2.5 mg/ml) was added to the coverslips for
1 h at 35 C. They were visualised with ALEXA 488-conjugated
secondary antibody (Molecular Probes, Leiden, Netherlands).
Chromatin was stained with DAPI to reveal nuclei (1:100 in 1% w/v
BSA in PBS) (Molecular Probes). The stained preparations were
mounted in hydromount mounting medium (National Diagnostics,
Hull, UK). Images were obtained using a CCD Upright Zeiss ﬂuo-
rescent microscope and Zeiss Axio vision 4.5 software. All images
were captured using the same time of exposure. Images were
processed to optimise to the peak ﬂuorescence.
2.5. Quantitative Real Time PCR (qRT–PCR)
Total RNA was isolated from quercetin-treated FHL-124 cells
using RNeasy mini column (Qiagen). RNA was reverse-transcribed
by reverse transcriptase (Superscript II, Invitrogen, Paisley, UK)
with random primers (Promega). The 25 ml PCR reactions were
performed using an ABI Prism 7700 Sequence Detection System
(Applied Biosystems, Foster City, CA) under the following condi-
tions: 50 C for 2 min, 95 C for 10 min, and then 40 cycles, each
Table 1
Genes for which mRNA levels were up- or down-regulated by quercetin (p < 0.01).
GenBank
Accession
No.
Common
Name
Description Fold
changea
Upregulated genes
X60673 AK3L1 adenylate kinase 3-like 1 2.99
AF002697 BNIP3 BCL2/adenovirus E1B 19kDa interacting
protein 3
2.84
AK000996 TMEM45A transmembrane protein 45A 2.43
NM_000291 PGK1 phosphoglycerate kinase 1 2.14
D87953 NDRG1 N-myc downstream regulated gene 1 1.80
AK000507 DDIT4 DNA-damage-indubible transcript 4 1.70
K03515 GPI glucose sulfate isomerase 1.69
AB037857 PTGFRN prostaglandin F2 receptor negative regulator 1.67
D25328 PFKP phosphofructokinase, platelet 1.63
AF109735 PFKFB3 6-phosphofructo-2-kinase/fructose-2,
6-biphosphatase 3
1.55
U25997 STC1 stanniocalcin 1 1.55
L07956 GBE1 glucan (1,4-alpha-), branching enzyme 1 1.54
J05032 DARS aspartyl-tRNA synthetase 1.52
AL162078 KLC4 kinesion light chain 4 1.50
L19686 MIF macrophage migration inhibitory factor
(glycosylation-inhibiting factor)
1.50
AL110269 WSB1 WD repeat and SOCS box-containing 1 1.46
AB032251 BPTF bromodomain PHD ﬁnger transcription
factor
1.44
AB014731 DENR density-regulated protein 1.41
AB023235 MTMR15 myotubularin related protein 15 1.41
AL137714 WASH2P WAS protein family homolog 2 pseudogene 1.40
Downregulated genes
M87507 CASP1 caspase 1, apoptosis-related cysteine
peptidase (inteleukin 1, beta, convertase)
0.64
U29344 FASN fatty acid synthase 0.61
AB000220 SEMA3C sema domain, immunoglobulin domain
(Ig) short basic domain, secreted,
(semaphorin) 3C
0.59
U70451 MYD88 myeloid differentiation primary
response gene (88)
0.58
X14787 THBS1 thrombospondin 1 0.57
X17025 IDI1 isopentenyl-diphosphate delta isomerase 1 0.54
AF026941 RSAD2 radical S-adenosyl methionine domain
containing 2
0.53
AK000080 SAMD9 sterile alpha motif domain containing 9 0.51
X66435 HMGCS1 3-hydroxy-3-methylglutaryl-Coenzyme A
synthase 1 (soluble)
0.47
M37984 TNNC1 troponin C type 1 (slow) 0.45
Genes highlighted in bold are regulated by HIF-1.
a Data are expressed as the relative -foldchange in gene expression for quercetin-
treated samples compared with the untreated control.
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probes were obtained fromApplied Biosystems (Assay-on-demand,
Applied Biosystems) for the following genes: BNIP3 (assay identi-
ﬁcation number Hs00969289_m1), EPO (Hs00171267_m1), PGK1
(Hs99999906_m1) and VEGF (Hs00173626_m1). In order to identify
stable genes for normalization, the geNorm method was used
(Vandesompele et al., 2002). Expression of the genes EIF4A2,
RPL13A and 18S was found to be the most stable. The geometric
mean of CT values of these three genes was used to normalize input
for each sample analyzed. The calculations were made using the
comparative CT method (DDCT) as previously reported (Livak and
Schmittgen, 2001; User Bulletin #2 Applied Biosystems). The data
were expressed as the relative-fold increase in gene expression for
quercetin-treated samples compared with the untreated control.
Statistical analysis was performed by unpaired, two-tailed Stu-
dent’s t test using Minitab release 14 (Minitab Inc, State College,
PA). The signiﬁcance level was set at p < 0.05.
2.6. Quantiﬁcation of VEGF protein
FHL-124 cells were grown onto 60 mm dishes and treated with
quercetin (24–72 h). A human VEGF ELISA kit (R&D Systems, Min-
neapolis, MN, USA) was employed to measure secreted VEGF
concentrations from a sample (200 ml) of medium. Total proteins
were extracted from each dish and used to normalize VEGF levels.
Statistical analysis was performed by unpaired, two-tailed Stu-
dent’s t test using Minitab release 14 (Minitab Inc, State College,
PA). The signiﬁcance level was set at p < 0.05.
3. Results
In order to investigate changes in gene expression in lens cells
caused by quercetin, gene array analyses were carried out using
FHL-124 cells exposed for 24 h to 10 mM quercetin. A comparison of
transcript proﬁles identiﬁed 20 genes for which increased expres-
sion was highly signiﬁcant (p < 0.01) and 10 genes for which
expression signiﬁcantly decreased (p < 0.01) (Table 1). Interest-
ingly, it was observed that 13/20 (65%) of the genes that showed
increased expression are reported in the literature to be regulated
by hypoxia and HIF-1 (Table 1).
Given that several HIF-1 regulated genes were upregulated in
response to quercetin in FHL-124 cells (Table 1), we looked at the
effects of quercetin on HIF-1a protein levels in these cells. HIF-1a is
the oxygen-sensitive subunit of the HIF-1 transcription factor
(Wang et al., 1995). It is a cytoplasmic proteinwhich during hypoxia
shows an increase in cellular levels and translocation to the
nucleus. In the nucleus it dimerises with HIF-1b to give the active
transcription factor HIF-1. In FHL-124 cells treated with 10 and
30 mM quercetin for 4 and 24 h, a large accumulation of HIF-1a
protein was induced. HIF-1a accumulation was greatest after 4 h at
the higher concentration (30 mM) but was detected after 24 h
following exposure to both 10 and 30 mM (Fig. 1A). A band of lower
molecular weight than the main band was observed at the higher
concentration of quercetin, which is likely to be due to a post-
translational modiﬁcation of the HIF-1 protein. HIF-1a band
intensities were quantiﬁed and normalized to b-actin (Fig. 1B). An
almost 70-fold increase in HIF-1a protein levels wasmeasured after
4 h incubation with 30 mM quercetin. At the 24 h time point, levels
were increased by approximately 15-fold with both 10 and 30 mM
quercetin.
The accumulation and translocation of HIF-1a to the nucleus
would indicate activation of HIF-1a and the induction of the
HIF-1 signaling pathway. Immunocytochemistry experiments
were carried out to look at the location of HIF-1a proteins within
the cells following quercetin treatment. When cells were exposedto 30 mM quercetin, there was a rapid change in HIF-1a status,
with a 30 min exposure being sufﬁcient to induce a large accu-
mulation of HIF-1a in the cells, with the highest density inside the
nucleus (Fig. 2). This accumulation was highest after 4 h, and
persisted for at least 24 h. HIF-1a was detectable in the untreated
cells, but at much lower levels than in quercetin-treated cells.
These data conﬁrm that there is an increase in HIF-1a with
quercetin, but more importantly, the data clearly show that HIF-1a
is translocated to the nucleus indicating HIF-1 pathway activation
in response to quercetin exposure.
To conﬁrm the activation of the HIF-1 signaling pathway, we
investigated the changes in transcript levels of four HIF-1 regulated
genes following quercetin treatment. BNIP3 and PGK1 had been
identiﬁed from the microarray study, whilst erythropoietin (EPO)
and vascular endothelial growth factor (VEGF or VEGF-A) were
selected because they are well-studied HIF-1 regulated genes. Cells
were exposed to 10 mM quercetin for 8, 24 or 48 h and the changes
in mRNA expression were measured by quantitative PCR. Signiﬁ-
cant increases were seen in expression of each of the genes at
the 24 and/or 48 h time points compared to controls (Fig. 3).
Fig. 1. Accumulation of HIF-1a in response to quercetin. FHL-124 cells were exposed to
quercetin (10 and 30 mM) for 4 and 24 h (A) HIF-1a protein levels were examined by
Western blot showing increased levels of HIF-1a with quercetin compared to the
normalising protein b-actin. (B) Amount of HIF-1a assessed by densitometric analysis
of Western blot data. Level is normalized to that of b-actin. Each bar represents the
mean  S.E.M. (arbitrary units) of 4 independent experiments. *p < 0.05 and **p < 0.01
relative to untreated cells at each time point.
P. Radreau et al. / Experimental Eye Research 89 (2009) 995–1002998The greatest upregulation of BNIP3 and VEGF (4-fold and 2.3-fold
respectively) was observed after 24 h quercetin exposure. For PGK1
and EPO, upregulation was highest after 48 h (2.6-fold and 1.8-fold
respectively). These data conﬁrm the activation of the HIF-1
signaling pathway by quercetin in FHL-124 cells.
To further investigate activation of the HIF-1 pathway by quer-
cetin, we measured secretion of VEGF by FHL-124 cells following
quercetin treatment (Fig. 4). For both quercetin concentrationsFig. 2. HIF-1a nuclear translocation in response to quercetin. Fluorescent micrographs sho
(blue). Cells were exposed to 30 mM quercetin for 0.5, 4 and 24 h. HIF-1a nuclear transloca(10 and 30 mM) and at all time points studied (24–72 h), there was
a signiﬁcant increase in VEGF secretion from quercetin-treated
compared to untreated cells. The increased VEGF secretion was
dose-dependent, and reached a maximum (3.5-fold) after 72 h
incubation with 30 mM quercetin. These data show that there are
sustained changes in the cell as a result of exposure to quercetin
associated with activation of the HIF-1 pathway.
Quercetin has previously been shown to chelate iron ions
(Leopoldini et al., 2006). HIF-1 prolyl hydroxylase (HPH) is an iron
dependent enzyme involved in the initial stages of oxygen sensi-
tivity of HIF-1a. When Fe2þ is chelated, the degradation of HIF-1a is
prevented and the subsequent accumulation of HIF-1a eventually
leads to HIF-1 activation. To investigate the role of Fe2þ in the
induction of HIF-1 by quercetin in FHL-124 cells, experiments were
performed in which excess Fe2þ was added to the culture medium.
We ﬁrst looked at HIF-1a protein accumulation in cells treatedwith
30 mM quercetin in the presence or absence of 100 mM FeSO4
(Fig. 5A and B). The large accumulation of HIF-1a observed with
quercetin alone was blocked in the presence of FeSO4. FeSO4 alone
had no effect on HIF-1a protein levels. The effects of Fe2þ on
quercetin-induced nuclear translocation of HIF-1a were also
investigated (Fig. 5C). Immunocytochemistry showed that nuclear
translocation of HIF-1a induced by quercetin was also prevented in
cells treated with quercetin together with excess FeSO4. FeSO4
alone did not cause an increase in HIF-1a in the nucleus. These data
suggest that the mechanism by which quercetin induces HIF-1
signaling pathway could involve Fe2þ chelation and subsequent
inhibition of prolyl hydroxylase (HPH) activity.4. Discussion
In this study we have investigated gene expression changes that
occur as a result of exposure to the bioﬂavonoid quercetin. Using
arrays, we found that the majority of genes that were upregulated
by quercetin were known to be controlled by the transcription
factor HIF-1. HIF-1 is involved in the co-ordination of the cellularwing HIF-1a (green) immunostaining of FHL-124 cells. Nuclei are labelled using DAPI
tion is observed subsequent to quercetin treatment, at all time points.
Fig. 3. Quercetin increases PGK1 (A), BNIP3 (B), EPO (C) and VEGF (D) mRNA levels in FHL-124 cells. Cells were treated with 10 mM quercetin for 8 (white bars), 24 (grey bars) and
48 h (black bars). Total RNA was extracted and qRT–PCR was performed. Data is expressed as relative-fold increase of quercetin-treated compared to untreated cells, after
normalization to 3 internal controls (see Materials and Methods for details). Each bar represents the mean  S.E.M. from 5 independent experiments. *p < 0.05 and **p < 0.01
relative to untreated cells.
P. Radreau et al. / Experimental Eye Research 89 (2009) 995–1002 999response to a lack of oxygen and regulation of oxygen homeostasis
(Semenza, 1998). It is a ubiquitously expressed heterodimer
composed of the two subunits HIF-1a and HIF-1b. The HIF-1b
subunit is constitutively expressed under all O2 conditions and is
located within the nucleus of the cell. The oxygen sensitivity of the
system is confered by the properties of HIF-1a (Dery et al., 2005;
Semenza, 2002). The processes involved are summarised in Fig. 6.
Under normoxic conditions, HIF-1a is hydroxylated on proline
residues 402 and 564 by the enzyme prolyl hydroxylase (HPH). HPH
requires the presence of iron (Fe2þ), O2 and 2-oxoglutarate as
cofactors in order to function effectively (Schoﬁeld and Ratcliffe,
2004). Hydroxylation causes the binding of HIF-1a to the von
Hippel–Landau tumour suppressor protein (VHL), targetting the
HIF-1a for ubiquitination by E3 ubiquitin-protein ligase which in
turn leads to degradation via the cytoplasmic proteosome. Under
conditions of normal O2 tension, HIF-1a is constantly synthesized,
but as a result of the processes described above, is immediately
targeted for degradation, giving it a half-life of approximately 5min
(Wang et al., 1995). This means that if there is an inhibition of this
process, then cellular HIF-1a levels can rapidly increase, as occurs
under conditions of low O2 tension. In hypoxia, the lack of avail-
ability of O2 means that hydroxylation cannot occur. HIF-1a no
longer binds to VHL and therefore is not targeted for degradation
causing a rapid increase in HIF-1a levels. It translocates to the
nucleus of the cell where it binds with HIF-1b forming the HIF-1Fig. 4. Quercetin increases the secretion of VEGF into FHL-124 cell media. Cells were
treated in absence (B) or presence of quercetin (10, (6) and 30 mM, (,)) for 0–72 h.
Secreted VEGF was measured and normalized as described in Materials and Methods.
Quercetin shows a dose- and time-dependent increase in VEGF secretion. Each point
represents the mean  S.E.M. of 4 independent experiments.transcription factor. HIF-1 then binds to the hypoxia-response
element (HRE) of target genes, inducing the expression of a suite of
genes that are involved in adaption to low oxygen conditions. Over
70 HIF-1 target genes have been identiﬁed (Semenza, 2004).
Erythropoietin (EPO) and vascular endothelial growth factor (VEGF
or VEGF-A), for example, are two well-studied HIF-1 regulated
genes, involved in increasing oxygen delivery to tissues via the
stimulation of red blood cell production and regulation of angio-
genesis respectively (Ferrara, 2000; Ridley et al., 1994). However, as
well as upregulating genes which are directly associated with
enabling the cell to adapt to low oxygen conditions, HIF regulatedFig. 5. Effect of FeSO4 on quercetin-induced HIF-1a accumulation in FHL-124 cells. Cells
were exposed to 30 mM quercetin in presence or absence of 100 mM FeSO4 for 2 h.
(A) Western blot of HIF-1a and b-actin protein. (B) Densitometric analysis of HIF-1a
normalized to b-actin. Each bar represents the mean  S.E.M. (arbitrary units) of 3
independent experiments. **p < 0.01 relative to untreated cells. (C) Fluorescent micro-
graphs showing DAPI (blue) and HIF-1a (green) immunostaining of FHL-124 cells.
Fig. 6. The HIF-1 signaling pathway, depicting cellular events under normal oxygen tensions and in hypoxia. The possible mechanism of action of quercetin in HIF-1 regulation as an
iron chelator is also shown. a ¼ HIF-1a, b ¼ HIF-1b, 2-OG ¼ 2-oxoglutarate, VHL ¼ von Hippel–Landau protein, HRE ¼ hypoxia-response element.
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cytoprotective properties (Castilla et al., 2000; Maiese et al., 2004).
It was therefore of interest that the majority of genes upregulated
by quercetin were HIF-1 regulated as this may contribute to the
cytoprotective properties of this ﬂavonoid. Investigating the effect
of quercetin on HIF-1 signaling in greater detail showed that
quercetin increased intracellular HIF-1a protein levels and caused
nuclear translocation. Four HIF-1 regulated genes were measured
by quantitative PCR and expression of each of these genes
increased. Moreover, there was a dose-dependent increase in VEGF
secretion by quercetin, which was maintained over a 72 h period.
Although there have been reports concerned with other cell types
showing that quercetin can upregulate genes via the HIF-1 pathway
(Triantafyllou et al., 2007; Wilson and Poellinger, 2002), this is the
ﬁrst report showing quercetin treatment has long-lasting effects,
sustained over 72 h. This study is also the ﬁrst to indicate the
relative dominance of this pathway in the expression response of
quercetin, with more than half the genes upregulated being
controlled via the HIF-1 pathway. Interestingly, none of the genes
highlighted by the array data are known to be regulated via the
antioxidant response element (ARE) and there were no indications
that other signaling pathways were involved. This does not
preclude a role for quercetin in other pathways in the lens, but in
our experiments the overriding regulator of expression seen was
HIF-1.
It is important to consider the mechanism by which quercetin
acts to stimulate the HIF-1 pathway. Quercetin is known to chelate
Fe2þ (Leopoldini et al., 2006) and it has been suggested that the
increase in HIF-1a is a direct result of this property (Jeon et al.,
2007; Park et al., 2007; Triantafyllou et al., 2007). Fe2þ is a cofactor
for HPH, an enzyme which catalyses the hydroxylation of HIF-1a
thus targeting it ultimately for degradation via the proteosome. In
the absence of Fe2þ this cannot occur and therefore HIF-1a is sta-
bilised and survives such that it can go on to activate HIF-1 regu-
lated genes. Fe2þ chelation therefore mimics the effects of hypoxic
conditions. Signiﬁcantly, the iron chelator 1,10-phrenanthroline has
been shown to increase HIF-1a levels in the rat lens in vivo
(Shui et al., 2008). In our experiments, adding an excess of Fe2þ
inhibited the effects of quercetin on HIF-1 pathway activation. Thepresence of excess Fe2þ would overcome the effects of quercetin-
mediated Fe2þ chelation, thus enabling sufﬁcient free Fe2þ in the
cell to support HPH activity. These data therefore suggest that the
major action of quercetin in stimulating the HIF-1 pathway is via
Fe2þ chelation and consequent inhibition of HPH. However, it
should be noted that there are alternative interpretations of these
data. It is also possible that when quercetin is bound to Fe2þ it is
unable to perform its usual actions within the cell, thus an excess of
Fe2þ would inhibit any effect of quercetin independent of the
mechanism involved.
Given the stimulation of the HIF-1 pathway by quercetin shown
in the experiments presented, it is interesting to look further at the
role of this pathway in the lens. As previously discussed, a major
downstream pathway of HIF-1 signaling is that mediated by VEGF,
a growth factor that is active in the stimulation of angiogenesis
(Ferrara, 2000; Leung et al., 1989). Despite the avascular nature of
the lens, adult lens has been shown to express both the VEGF-A
protein and the VEGF receptor, VEGFR2, indicating active VEGF
signaling in the lens (Gilbert et al., 1998; Shui et al., 2003). Further,
VEGF signaling appeared to be sensitive to the levels of oxygen
(Shui et al., 2003). These observations led to investigation of the
role of the HIF-1 pathway in the lens and an elegant series of
experiments have demonstrated an important role for signaling via
this pathway in lens growth (Shui et al., 2008; Shui and Beebe,
2008). The hypoxic environment of the lens is sufﬁcient to activate
the HIF-1 pathway, which has been shown to be constitutively
active in the lens (Shui et al., 2008; Shui and Beebe, 2008). Lens
growth is known to decline with age in all species and in rat an
approximately 3-fold decrease in lens epithelial cell proliferation
occurs between months 1 and 8 after birth (Shui and Beebe, 2008).
Increasing the oxygen around the lens in 8month old rats increased
levels of proliferation back to that of a 1month old animal (Shui and
Beebe, 2008). These experiments indicate that the decrease in lens
growth with age is caused by the decrease in oxygen (Shui and
Beebe, 2008) and that this is mediated by HIF signaling (Shui et al.,
2008). Moreover, using a conditional knock-out system, it was
shown that expression of HIF-1a is necessary for the normal growth
of the lens and survival of ﬁbre cells (Shui et al., 2008). It appears
therefore that HIF signaling plays a fundamental role in the lens. It
P. Radreau et al. / Experimental Eye Research 89 (2009) 995–1002 1001has been further postulated that the observed HIF-dependent
suppression of growth is important in protecting the lens against
nuclear cataract (Shui and Beebe, 2008). Epidemiological data has
shown that as the size of the lens increases, there is an increased
risk of nuclear cataract formation (Klein et al., 1998, 2000). Inap-
propriate lens epithelial cell proliferation could be a contributing
factor in nuclear cataract and agents, such as quercetin, which
stimulate the HIF-1 pathway could therefore potentially decrease
the risk of cataract formation.
A recent study looking at quercetin and its interaction with the
HIF-1 pathway raises important questions to be considered in
relation to the lens. Triantafyllou et al. (2008) used HeLa cells to
investigate the effects of ﬂavonoids on HIF-1a. It was found that as
well as an increase in HIF-1a levels, that quercetin (100 mM) also
inhibited translocation of HIF-1a to the nucleus via the p44/42
MAPK pathway. This inhibition became more apparent when the
HIF-1 pathway was stimulated either by iron chelation or hypoxia
(1% O2). Our data clearly show intense HIF-1a staining in the
nucleus, with little remaining in the cytoplasm of cells treated with
quercetin (30 mM) (Fig. 2), suggesting that nuclear translocation of
HIF-1awas not signiﬁcantly inhibited in our experiments. Whether
these differences are, for example, due to the concentration of
quercetin used, or differences between cell lines remains to be
determined, but certainly given that the lens exists under condi-
tions of relative hypoxia (approximately 3% O2) (Shui et al., 2008;
Shui and Beebe, 2008) and that the HIF-1 pathway is constitutively
active in lens, it will be very important to investigate signaling in
lens epithelial cells under conditions of differing O2 tension.
In considering quercetin as an agent that could reduce the risk of
cataract formation, it is plausible that quercetin could act via
multiple pathways. Oxidative stress is a recognised factor in the
formation of cataract (Spector, 1995; Taylor et al., 1995; Truscott,
2005) and quercetin, as a potent antioxidant, could directly inhibit
oxidative damage. Indeed this has already been suggested and
quercetin treatment has been shown to decrease lens opacity in an
oxidative model of cataract (Sanderson et al., 1999). As a result of
the experiments presented here, it will be important to investigate
the role of HIF-1 signaling in cytoprotection as this could also
contribute to any potential anti-cataract activity. It will also be of
key importance to investigate the effects of quercetin on HIF-1
activation under conditions of reduced oxygen in order to speciﬁ-
cally relate to the conditions experienced by the lens in vivo. In
addition, the bioavailability of quercetin to the lens requires
consideration. Peak plasma concentrations of total quercetin
(largely as quercetin metabolites) are reported in the low micro-
molar range (up to 7.6 mM) (Manach et al., 2005) in bioavailability
studies following intake of a quercetin-rich food (onion). Whether
quercetin reaches the lens and in what form is an important
question for future research.Acknowledgements
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